Business Description
CombiGene AB
ISIN : SE0016101935
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 5.75 | |||||
Beneish M-Score | -2.72 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 16.6 | |||||
3-Year EPS without NRI Growth Rate | 18.4 | |||||
3-Year FCF Growth Rate | 28.9 | |||||
3-Year Book Growth Rate | -0.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.01 | |||||
9-Day RSI | 50.67 | |||||
14-Day RSI | 47.07 | |||||
6-1 Month Momentum % | 47.27 | |||||
12-1 Month Momentum % | -45.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.77 | |||||
Quick Ratio | 14.77 | |||||
Cash Ratio | 14.53 | |||||
Days Sales Outstanding | 178.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1031.31 | |||||
Net Margin % | -952 | |||||
FCF Margin % | -815.69 | |||||
ROE % | -28.88 | |||||
ROA % | -27.61 | |||||
ROIC % | -166.35 | |||||
ROC (Joel Greenblatt) % | -4250.9 | |||||
ROCE % | -28.87 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 18.34 | |||||
PB Ratio | 0.66 | |||||
Price-to-Tangible-Book | 0.78 | |||||
EV-to-EBIT | 0.64 | |||||
EV-to-EBITDA | 0.7 | |||||
EV-to-Revenue | -6.16 | |||||
EV-to-FCF | 0.93 | |||||
Price-to-Net-Current-Asset-Value | 0.79 | |||||
Price-to-Net-Cash | 0.8 | |||||
Earnings Yield (Greenblatt) % | 155.17 | |||||
FCF Yield % | -44.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CombiGene AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 3.702 | ||
EPS (TTM) (kr) | -1.78 | ||
Beta | 0 | ||
Volatility % | 65.14 | ||
14-Day RSI | 47.07 | ||
14-Day ATR (kr) | 0.214681 | ||
20-Day SMA (kr) | 3.467 | ||
12-1 Month Momentum % | -45.36 | ||
52-Week Range (kr) | 2 - 7.86 | ||
Shares Outstanding (Mil) | 19.8 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CombiGene AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CombiGene AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
CombiGene AB Frequently Asked Questions
What is CombiGene AB(OSTO:COMBI)'s stock price today?
When is next earnings date of CombiGene AB(OSTO:COMBI)?
Does CombiGene AB(OSTO:COMBI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |